Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability

References

• Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4:448 - 456
   PubMed Web of Science ®Google Scholar
• Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007; 28:297 - 321
   PubMed Web of Science ®Google Scholar
• Varani J. Interaction of tumor cells with the extracellular matrix. Revis Biol Celular 1987; 12:1 - 113
   PubMedGoogle Scholar
• Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006; 12:895 - 904
   PubMed Web of Science ®Google Scholar
• Devi GR. Prostate cancer: status of current treatments and emerging antisense-based therapies. Curr Opin Mol Ther 2002; 4:138 - 148
   PubMed Web of Science ®Google Scholar
• Fallowfield LJ. Evolution of breast cancer treatments: current options and quality-of-life considerations. Eur J Oncol Nurs 2004; 8:75 - 82
   PubMedGoogle Scholar
• Theobald DE. Cancer pain, fatigue, distress and insomnia in cancer patients. Clin Cornerstone 2004; 6:15 - 21
   PubMedGoogle Scholar
• Amado F, Lourenco MT, Deheinzelin D. Metastatic breast cancer: do current treatments improve quality of life? A prospective study. Sao Paulo Med J 2006; 124:203
   PubMedGoogle Scholar
• Mattox TW. Treatment of unintentional weight loss in patients with cancer. Nutr Clin Pract 2005; 20:400 - 410
   PubMedGoogle Scholar
• Perez-Tomas R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 2006; 13:1859 - 1876
   PubMed Web of Science ®Google Scholar
• Lehnert M. Multidrug resistance in human cancer. J Neurooncol 1994; 22:239 - 243
   PubMed Web of Science ®Google Scholar
• Sinha S, Jain S. Natural products as anticancer agents. Prog Drug Res 1994; 42:53 - 132
   PubMedGoogle Scholar
• Parkinson DR, Arbuck SG, Moore T, Pluda JM, Christian MC. Clinical development of anticancer agents from natural products. Stem Cells 1994; 12:30 - 43
   PubMed Web of Science ®Google Scholar
• Nielsen FH. The emergence of boron as nutritionally important throughout the life cycle. Nutrition 2000; 16:512 - 514
   PubMed Web of Science ®Google Scholar
• Woods WG. An introduction to boron: history, sources, uses and chemistry. Environ Health Perspect 1994; 102:5 - 11
   PubMed Web of Science ®Google Scholar
• Cui Y, Winton MI, Zhang ZF, Rainey C, Marshall J, De Kernion JB, Eckhert CD. Dietary boron intake and prostate cancer risk. Oncol Rep 2004; 11:887 - 892
   PubMed Web of Science ®Google Scholar
• Barranco WT, Eckhert CD. Boric acid inhibits human prostate cancer cell proliferation. Cancer Lett 2004; 216:21 - 29
   PubMed Web of Science ®Google Scholar
• Barranco WT, Eckhert CD. Cellular changes in boric acid-treated DU-145 prostate cancer cells. Br J Cancer 2006; 94:884 - 890
   PubMed Web of Science ®Google Scholar
• Barranco WT, Hudak PF, Eckhert CD. Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States). Cancer Causes Control 2007; 18:71 - 77
   PubMed Web of Science ®Google Scholar
• Gallardo-Williams MT, Chapin RE, King PE, Moser GJ, Goldsworthy TL, Morrison JP, Maronpot RR. Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice. Toxicol Pathol 2004; 32:73 - 78
   PubMed Web of Science ®Google Scholar
• Gallardo-Williams MT, Maronpot RR, Wine RN, Brunssen SH, Chapin RE. Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid. Prostate 2003; 54:44 - 49
   PubMed Web of Science ®Google Scholar
• Rust WL, Huff JL, Plopper GE. Screening assay for promigratory/antimigratory compounds. Anal Biochem 2000; 280:11 - 19
   PubMed Web of Science ®Google Scholar
• Klees RF, De Marco PC, Salasznyk RM, Ahuja D, Hogg M, Antoniotti S, Kamath L, Dordick JS, Plopper GE. Apocynin derivatives interrupt intracellular signaling resulting in decreased migration in breast cancer cells. J Biomed Biotechnol 2006; 2006:87246
   PubMed Web of Science ®Google Scholar
• Plopper GE, Domanico SZ, Cirulli V, Kiosses WB, Quaranta V. Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types. Breast Cancer Res Treat 1998; 51:57 - 69
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55 - 63
   PubMed Web of Science ®Google Scholar
• Meacham SL, Hunt CD. Dietary boron intakes of selected populations in the United States. Biol Trace Elem Res 1998; 66:65 - 78
   PubMed Web of Science ®Google Scholar
• Groziak MP. Boron therapeutics on the horizon. Am J Ther 2001; 8:321 - 328
   PubMedGoogle Scholar
• Yang W, Gao X, Wang B. Boronic acid compounds as potential pharmaceutical agents. Med Res Rev 2003; 23:346 - 368
   PubMed Web of Science ®Google Scholar
• Hunt CD. Regulation of enzymatic activity: one possible role of dietary boron in higher animals and humans. Biol Trace Elem Res 1998; 66:205 - 225
   PubMed Web of Science ®Google Scholar
• Nielsen FH. The justification for providing dietary guidance for the nutritional intake of boron. Biol Trace Elem Res 1998; 66:319 - 330
   PubMed Web of Science ®Google Scholar
• Rainey CJ, Nyquist LA, Christensen RE, Strong PL, Culver BD, Coughlin JR. Daily boron intake from the American diet. J Am Diet Assoc 1999; 99:335 - 340
   PubMed Web of Science ®Google Scholar
• Clinton SK, Giovannucci E. Diet, nutrition and prostate cancer. Annu Rev Nutr 1998; 18:413 - 440
   PubMed Web of Science ®Google Scholar
• Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007; 99:1200 - 1209
   PubMed Web of Science ®Google Scholar
• Stacewicz-Sapuntzakis M, Borthakur G, Burns JL, Bowen PE. Correlations of dietary patterns with prostate health. Mol Nutr Food Res 2008; 52:114 - 130
   PubMed Web of Science ®Google Scholar
• Jansen JA, Andersen J, Schou JS. Boric acid single dose pharmacokinetics after intravenous administration to man. Arch Toxicol 1984; 55:64 - 67
   PubMed Web of Science ®Google Scholar
• Schou JS, Jansen JA, Aggerbeck B. Human pharmacokinetics and safety of boric acid. Arch Toxicol Suppl 1984; 7:232 - 235
   PubMedGoogle Scholar
• Linden CH, Hall AH, Kulig KW, Rumack BH. Acute ingestions of boric acid. J Toxicol Clin Toxicol 1986; 24:269 - 279
   PubMed Web of Science ®Google Scholar
• Litovitz TL, Klein-Schwartz W, Oderda GM, Schmitz BF. Clinical manifestations of toxicity in a series of 784 boric acid ingestions. Am J Emerg Med 1988; 6:209 - 213
   PubMed Web of Science ®Google Scholar
• Moseman RF. Chemical disposition of boron in animals and humans. Environ Health Perspect 1994; 102:113 - 117
   PubMed Web of Science ®Google Scholar
• Scorei R, Ciubar R, Ciofrangeanu CM, Mitran V, Cimpean A, Iordachescu D. Comparative Effects of Boric Acid and Calcium Fructoborate on Breast Cancer Cells. Biol Trace Elem Res 2008;
   PubMed Web of Science ®Google Scholar
• Shan D, Chen L, Njardarson JT, Gaul C, Ma X, Danishefsky SJ, Huang XY. Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc Natl Acad Sci USA 2005; 102:3772 - 3776
   PubMed Web of Science ®Google Scholar
• Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, et al. Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer 2007; 60:200 - 207
   PubMed Web of Science ®Google Scholar
• Ram VJ, Kumari S. Natural products of plant origin as anticancer agents. Drug News Perspect 2001; 14:465 - 482
   PubMed Web of Science ®Google Scholar
• Gordaliza M. Natural products as leads to anticancer drugs. Clin Transl Oncol 2007; 9:767 - 776
   PubMed Web of Science ®Google Scholar